FDA accepts NDA for extended-release Janumet for type 2 diabetes - MPR
Links shared publicly online about this topic.
- 584total visits
FDA accepts NDA for extended-release Janumet for type 2 diabetes - MPR
empr.com —
View full resource at empr.com
Tags: Diabetes, Type 2 Diabetes, Drug, FDA, Merck & Co., News
Most Recently Shared on January 13, 2011 at 3:38 pm By:
MPR News: FDA accepts NDA for extended-release Janumet for type 2 diabetes: Merck announced that the New Drug Ap... http://bit.ly/hVcolP
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(R) For Type 2 Diabetes | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(R) For Type 2 Diabetes | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on January 13, 2011 at 5:04 pm By:
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended… http://goo.gl/fb/AADbh
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(R) For Type 2 Diabetes
medicalnewstoday.com — “Merck announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S.” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 3:05 pm By:
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(... http://mnt.to/3PWH
Advertisement
